Details of the Drug

General Information of Drug (ID: DMNWGOE)

Drug Name

1-Benzyl-3-thiazol-2-yl-thiourea

Synonyms

1-Benzyl-3-thiazol-2-yl-thiourea; Thiourea, N-(phenylmethyl)-N'-2-thiazolyl-; 51623-90-6; BAS 00581141; 1-benzyl-3-(1,3-thiazol-2-yl)thiourea; PETT Bz deriv.; PETT Analog 30; AC1LDT48; MLS001208035; BDBM1923; SCHEMBL5455503; CHEMBL145897; REGID_for_CID_700723; CTK1G4420; ZINC80959; DTXSID90351457; PDHMEDMWKUZUAB-UHFFFAOYSA-N; MolPort-000-656-277; N-(benzyl)-N'-[2-thiazolyl]thiourea; AKOS000533873; 1-benzyl-3-1,3-thiazol-2-ylthiourea; MCULE-4774117095; N-(benzyl)-N'-[2-thiazolyl] thiourea; SMR000514687

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

249.4

Topological Polar Surface Area (xlogp)

2.4

Rotatable Bond Count (rotbonds)

3

Hydrogen Bond Donor Count (hbonddonor)

2

Hydrogen Bond Acceptor Count (hbondacc)

3

Chemical Identifiers

Formula: C11H11N3S2
IUPAC Name: 1-benzyl-3-(1,3-thiazol-2-yl)thiourea
Canonical SMILES: C1=CC=C(C=C1)CNC(=S)NC2=NC=CS2
InChI: InChI=1S/C11H11N3S2/c15-10(14-11-12-6-7-16-11)13-8-9-4-2-1-3-5-9/h1-7H,8H2,(H2,12,13,14,15)
InChIKey: PDHMEDMWKUZUAB-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 700723
CAS Number: 51623-90-6
TTD ID: D0L2CG

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Human immunodeficiency virus Reverse transcriptase (HIV RT)	TT84ETX	POL_HV1B1	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relati... J Med Chem. 1995 Dec 8;38(25):4929-36.
2	Antiviral drugs in current clinical use. J Clin Virol. 2004 Jun;30(2):115-33.
3	HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.Nat Struct Mol Biol.2012 Jan 22;19(2):253-9.
4	A peptide inhibitor of HIV-1 reverse transcriptase using alpha,beta-dehydro residues: a structure-based computer model. J Biomol Struct Dyn. 1998 Oct;16(2):347-54.
5	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
6	Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only Curr HIV Res. 2009 May;7(3):320-6.
7	Emerging antiviral drugs. Expert Opin Emerg Drugs. 2008 Sep;13(3):393-416.
8	2008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.